SPRY logo

ARS PHARMACEUTICALS INC

SPRYNASDAQ
πŸ† #3166 by market capEarnings Mar 8US Equity
$2.96β–Ό $0.40 (βˆ’11.90%)
Market closed Β· at close
πŸ””
Track SPRY
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 11.9%
7dβ–Ό 24.1%
14dβ–² 6.7%
30dβ–Ό 26.5%
ytdβ–Ό 74.6%
1yβ–Ό 61.1%
🏦Market Cap
$294M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-14.4%
Declining
πŸ“ŠGross Margin
71.0%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
2.4x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$2.85 – $3.46
52-Week Range
$2.44 – $13.15
Volume (shares)
2,784,261
Avg Volume (shares)
β€”
Shares Outstanding
99.5M
Next Earnings
2027-03-08

Fundamentals Snapshot

Annual Revenue
$84M
Last Q Revenue
$38M
P/E Ratio
β€”
P/S Ratio
2.4x
EPS (TTM)
$-2.01
Dividend Yield
β€”
Dilution (1yr)
+0.6%
SPRY logo

ARS PHARMACEUTICALS INC

SPRY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$84Mβ–Ό βˆ’5.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
75.8%β–Ό βˆ’1.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$179Mβ–² +5720.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$171Mβ–Ό βˆ’1418.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
98.6Mβ–² +0.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$55Mβ–Ό βˆ’$106M YoY
StockOtter Β· stockotter.space

About ARS PHARMACEUTICALS INC

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100
Analyst data unavailable.

Latest News & Updates

News unavailable.